Role of CTLA4 immunohistochemistry in the diagnosis of colon cancers

Background: There are a wide range of diagnostic markers for colorectal cancers like detection of mutated KRAS, TP53, and APC genes. However, genetic and immunological factors have also been attributed to the cancer prognosis. The present study was carried out to evaluate the expression of CTLA-4 in...

Full description

Bibliographic Details
Main Authors: Vishnu Narayanan, V Pavithra, Divya Dhanapal, Sandhya Sundaram, C D Narayanan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Indian Journal of Pathology and Microbiology
Subjects:
Online Access:http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2022;volume=65;issue=4;spage=791;epage=795;aulast=Narayanan
_version_ 1797963477849997312
author Vishnu Narayanan
V Pavithra
Divya Dhanapal
Sandhya Sundaram
C D Narayanan
author_facet Vishnu Narayanan
V Pavithra
Divya Dhanapal
Sandhya Sundaram
C D Narayanan
author_sort Vishnu Narayanan
collection DOAJ
description Background: There are a wide range of diagnostic markers for colorectal cancers like detection of mutated KRAS, TP53, and APC genes. However, genetic and immunological factors have also been attributed to the cancer prognosis. The present study was carried out to evaluate the expression of CTLA-4 in colorectal cancers. Methods: This cross-sectional study was carried out among 30 resected specimens of colorectal cancer. Paraffin blocks were made on samples from tumor areas along with adjacent normal areas. Immunohistochemistry for CTLA-4 was done on the sections along with controls. Gross findings were recorded from the blocks. Blocks with section containing normal epithelium and tumor were chosen for immunohistochemistry. Results: Overexpression of CTLA-4 was observed in 43.3% of the tumors. There was a significantly high tumor infiltration among those specimens showing overexpression of CTLA-4. The observed difference was statistically significant (P < 0.05). On comparing the grade of the tumor with intensity of CTLA4 uptake, it was observed that majority of the well-differentiated tumors (66.7%) had an intensity of 1+ whereas majority of the poorly differentiated tumors had an intensity of 3+ (66.7%). Conclusion: The present study has demonstrated overexpression of CTLA-4 in colorectal cancer specimens, and also highlighted the potential scope for anti-CTLA-4 agents like Ipilimumab in cancer therapy. The need for further evaluation to examine five-year survival with such immunotherapies is essential to document candid therapeutic recommendations for colorectal cancers.
first_indexed 2024-04-11T01:30:02Z
format Article
id doaj.art-14ba46cecf9c45a8a142f20f841a38ea
institution Directory Open Access Journal
issn 0377-4929
language English
last_indexed 2024-04-11T01:30:02Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Pathology and Microbiology
spelling doaj.art-14ba46cecf9c45a8a142f20f841a38ea2023-01-03T09:56:32ZengWolters Kluwer Medknow PublicationsIndian Journal of Pathology and Microbiology0377-49292022-01-0165479179510.4103/ijpm.ijpm_112_21Role of CTLA4 immunohistochemistry in the diagnosis of colon cancersVishnu NarayananV PavithraDivya DhanapalSandhya SundaramC D NarayananBackground: There are a wide range of diagnostic markers for colorectal cancers like detection of mutated KRAS, TP53, and APC genes. However, genetic and immunological factors have also been attributed to the cancer prognosis. The present study was carried out to evaluate the expression of CTLA-4 in colorectal cancers. Methods: This cross-sectional study was carried out among 30 resected specimens of colorectal cancer. Paraffin blocks were made on samples from tumor areas along with adjacent normal areas. Immunohistochemistry for CTLA-4 was done on the sections along with controls. Gross findings were recorded from the blocks. Blocks with section containing normal epithelium and tumor were chosen for immunohistochemistry. Results: Overexpression of CTLA-4 was observed in 43.3% of the tumors. There was a significantly high tumor infiltration among those specimens showing overexpression of CTLA-4. The observed difference was statistically significant (P < 0.05). On comparing the grade of the tumor with intensity of CTLA4 uptake, it was observed that majority of the well-differentiated tumors (66.7%) had an intensity of 1+ whereas majority of the poorly differentiated tumors had an intensity of 3+ (66.7%). Conclusion: The present study has demonstrated overexpression of CTLA-4 in colorectal cancer specimens, and also highlighted the potential scope for anti-CTLA-4 agents like Ipilimumab in cancer therapy. The need for further evaluation to examine five-year survival with such immunotherapies is essential to document candid therapeutic recommendations for colorectal cancers.http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2022;volume=65;issue=4;spage=791;epage=795;aulast=Narayanancolorectal cancersctla-4immunohistochemistryt lymphocytes
spellingShingle Vishnu Narayanan
V Pavithra
Divya Dhanapal
Sandhya Sundaram
C D Narayanan
Role of CTLA4 immunohistochemistry in the diagnosis of colon cancers
Indian Journal of Pathology and Microbiology
colorectal cancers
ctla-4
immunohistochemistry
t lymphocytes
title Role of CTLA4 immunohistochemistry in the diagnosis of colon cancers
title_full Role of CTLA4 immunohistochemistry in the diagnosis of colon cancers
title_fullStr Role of CTLA4 immunohistochemistry in the diagnosis of colon cancers
title_full_unstemmed Role of CTLA4 immunohistochemistry in the diagnosis of colon cancers
title_short Role of CTLA4 immunohistochemistry in the diagnosis of colon cancers
title_sort role of ctla4 immunohistochemistry in the diagnosis of colon cancers
topic colorectal cancers
ctla-4
immunohistochemistry
t lymphocytes
url http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2022;volume=65;issue=4;spage=791;epage=795;aulast=Narayanan
work_keys_str_mv AT vishnunarayanan roleofctla4immunohistochemistryinthediagnosisofcoloncancers
AT vpavithra roleofctla4immunohistochemistryinthediagnosisofcoloncancers
AT divyadhanapal roleofctla4immunohistochemistryinthediagnosisofcoloncancers
AT sandhyasundaram roleofctla4immunohistochemistryinthediagnosisofcoloncancers
AT cdnarayanan roleofctla4immunohistochemistryinthediagnosisofcoloncancers